US Stock Market Move | Weight loss drug concept stocks are strong, with Suodi Biotech (GPCR.US) rising more than 5%.
US weight loss pill concept stocks strengthen, as of the time of writing, Shuodi Bioscience's stock is up more than 5%.
On Wednesday, the concept stocks of weight loss drugs in the US stock market performed well. As of the deadline, Shodex Biotechnology (GPCR.US) rose by over 5%, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) rose by over 3.5%, Roche (RHHBY.US) rose by over 3%, and Eli Lilly (LLY.US) rose slightly. In terms of news, Shodex Biotechnology previously announced positive top-line results for its once-daily, orally administered small molecule GLP-1 receptor agonist aleniglipron in the ACCESS clinical trial.
Related Articles
US Stock Market Move | Stock prices continued to fall, with Broadcom Inc. (AVGO.US) dropping over 4%, and its high growth performance being questioned.
US Stock Market Move | Planned $7 billion acquisition of cybersecurity company Armis ServiceNow (NOW.US) leads to a drop of over 10%
US Stock Market Move | Hot Chinese concept stocks collectively fell, Alibaba Group Holding Limited Sponsored ADR (BABA.US) fell more than 3%.
US Stock Market Move | Stock prices continued to fall, with Broadcom Inc. (AVGO.US) dropping over 4%, and its high growth performance being questioned.
US Stock Market Move | Planned $7 billion acquisition of cybersecurity company Armis ServiceNow (NOW.US) leads to a drop of over 10%
US Stock Market Move | Hot Chinese concept stocks collectively fell, Alibaba Group Holding Limited Sponsored ADR (BABA.US) fell more than 3%.
RECOMMEND
Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025
Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025
Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025
